TY - JOUR
T1 - Comparing outcomes of diabetic ketoacidosis hospitalisations in patients with diastolic heart failure
T2 - A retrospective propensity matched analysis of the nationwide inpatient sample
AU - Shaka, Hafeez
AU - El-Amir, Zain
AU - Aljadah, Michael
AU - Wani, Farah
AU - Velazquez, Genero
AU - Kichloo, Asim
N1 - Publisher Copyright:
© 2021 John Wiley & Sons Ltd.
PY - 2021/10
Y1 - 2021/10
N2 - Introduction: Diabetic ketoacidosis (DKA) is a known complication of patients with diabetes mellitus. The aim of this study was to compare the outcomes of patients admitted with a diagnosis of DKA with, and without, diastolic heart failure (DHF). Methods: This was a population-based, retrospective, observational study using data from the National Inpatient Sample database for the years 2016 and 2017. The primary outcome was in-hospital mortality. Secondary outcomes were rates of sepsis, non-ST elevation myocardial infarctions (NSTEMI), acute kidney failure, acute respiratory failure (ARF), deep vein thrombosis, pulmonary embolism, mean length of hospital stay (LOS) and total hospital charges (THC). Results: There was no statistically significant difference for the adjusted odds for in-hospital mortality between patients with and without DHF (adjusted odds ratio [aOR]: 0.55, 95% confidence interval [CI] 0.28–1.08, p = 0.081). Patients with DKA and DHF had increased odds of developing an NSTEMI (aOR: 1.31, 95% CI: 1.01–1.70, p = 0.045) or ARF (aOR: 1.82, 95% CI: 1.38–2.40, p < 0.001) during the same admission compared to patients without DHF. Patients with DKA and DHF also had an increased mean THC (6500 CI: 1900–11,200, p = 0.0006) in US dollars and increased LOS (0.7, 95% CI: 0.2–1.3, p = 0.011) in days when compared to patients without DHF. Conclusions: Patients with DKA showed no statistically significant difference in mortality if they did or did not have a secondary diagnosis of DHF within the same admission.
AB - Introduction: Diabetic ketoacidosis (DKA) is a known complication of patients with diabetes mellitus. The aim of this study was to compare the outcomes of patients admitted with a diagnosis of DKA with, and without, diastolic heart failure (DHF). Methods: This was a population-based, retrospective, observational study using data from the National Inpatient Sample database for the years 2016 and 2017. The primary outcome was in-hospital mortality. Secondary outcomes were rates of sepsis, non-ST elevation myocardial infarctions (NSTEMI), acute kidney failure, acute respiratory failure (ARF), deep vein thrombosis, pulmonary embolism, mean length of hospital stay (LOS) and total hospital charges (THC). Results: There was no statistically significant difference for the adjusted odds for in-hospital mortality between patients with and without DHF (adjusted odds ratio [aOR]: 0.55, 95% confidence interval [CI] 0.28–1.08, p = 0.081). Patients with DKA and DHF had increased odds of developing an NSTEMI (aOR: 1.31, 95% CI: 1.01–1.70, p = 0.045) or ARF (aOR: 1.82, 95% CI: 1.38–2.40, p < 0.001) during the same admission compared to patients without DHF. Patients with DKA and DHF also had an increased mean THC (6500 CI: 1900–11,200, p = 0.0006) in US dollars and increased LOS (0.7, 95% CI: 0.2–1.3, p = 0.011) in days when compared to patients without DHF. Conclusions: Patients with DKA showed no statistically significant difference in mortality if they did or did not have a secondary diagnosis of DHF within the same admission.
KW - cardiovascular diseases
KW - diabetes mellitus
KW - diabetic ketoacidosis
KW - diastolic heart failure
KW - mortality
UR - http://www.scopus.com/inward/record.url?scp=85099861520&partnerID=8YFLogxK
U2 - 10.1002/dmrr.3435
DO - 10.1002/dmrr.3435
M3 - Article
AN - SCOPUS:85099861520
SN - 1520-7552
VL - 37
JO - Diabetes/Metabolism Research and Reviews
JF - Diabetes/Metabolism Research and Reviews
IS - 7
M1 - e3435
ER -